Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omission of perioperative antibiotic prophylaxis in acute calculous cholecystitis surgery
NL-OMON24030Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Mar 2016
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of cefazolin in acute calculous cholecystitis (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Development of postoperative infections. Started Mar 2016; status: active, not recruiting.
02
Drugs
cefazolin
03
Conditions
acute calculous cholecystitis
Beyond the preview
Go deeper on NL-OMON24030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24030.